Enliven Therapeutics (ELVN) Capital Expenditures (2019 - 2026)
Enliven Therapeutics (ELVN) reported Capital Expenditures of $99,000 for Q2 2026, down 28.8% from $139,000 a year earlier.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Capital Expenditures (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enliven Therapeutics' Capital Expenditures came in at $98,000, down 45.9% year-over-year; for FY2025, it came in at $158,000, up 259.1% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 54.4% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $44,000 in FY2024 (-70.5%), $149,000 in FY2023 (-75.7%), $612,000 in FY2022 and $12,000 in FY2021 (-33.3%).
- Five-year quarterly Capital Expenditures spans a low of -$1,000 in Q3 2025 and a high of $303,000 in Q2 2022.
- The high point for year-over-year Capital Expenditures in five years was Q3 2024 (growth of 37.5%); the low point was Q2 2024 (a decline of 97.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Enliven Therapeutics | 2.77 Bn | 482.20 Mn | - | 99,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 88,000.00 |
| Mar 31, 2023 | 31,000.00 |
| Dec 31, 2022 | 101,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 303,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Mar 31, 2021 | 12,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 15,000.00 |
| Sep 30, 2019 | 59,000.00 |
API Access
Enliven Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();